Fluorescence Kinetics of Aluminium Phthalocyanine Disulphonate in Tumors
Author Information
Author(s): MJH Witjes, OC Speelman, PGJ Nikkels, CAAM Nooren, JM Nautal, B van der Holt, HLLM van Leengoed, WM Star, JLN Roodenburg
Primary Institution: University Hospital, Groningen; Dr Daniel den Hoed Cancer Center, Rotterdam
Hypothesis
Can aluminium phthalocyanine disulphonate (AlPcS2) be used effectively for the detection of cancer through fluorescence in an autologous tumor model?
Conclusion
AlPcS2 can be used for photodiagnosis of premalignant and malignant disorders in epithelium, with optimal fluorescence detection occurring between 2 and 10 hours after injection.
Supporting Evidence
- Fluorescence intensity increased significantly with the severity of dysplasia (P<0.04).
- 67% of strong fluorescent spots showed local alterations in the mucosa.
- AlPcS2 fluorescence was detected optimally between 2 and 10 hours after injection.
- Only 29% of biopsies from fluorescent hotspots were confirmed as squamous cell carcinoma.
- The study used a well-defined animal model that closely resembles human squamous cell carcinoma.
Takeaway
This study shows that a special dye can help doctors find cancer in the mouth by glowing under certain lights, especially if they look for it a few hours after giving the dye.
Methodology
Wistar albino rats were treated with 4-nitroquinoline 1-oxide to induce dysplasia and cancer, then injected with AlPcS2, and fluorescence images were recorded at various time points.
Potential Biases
Potential bias in histological assessment as the observer was unaware of treatment timing.
Limitations
The study's findings may not be applicable to other types of tumors or tissues outside the oral cavity.
Participant Demographics
Wistar albino rats were used in the study.
Statistical Information
P-Value
p<0.04
Statistical Significance
p<0.04
Want to read the original?
Access the complete publication on the publisher's website